MYR GROUP INC/DELAWARE (MYRG) Fundamental Analysis & Valuation

NASDAQ:MYRG • US55405W1045

267.31 USD
+6.41 (+2.46%)
At close: Mar 9, 2026
267.31 USD
0 (0%)
After Hours: 3/9/2026, 8:24:10 PM

This MYRG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

MYRG gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 56 industry peers in the Construction & Engineering industry. While MYRG has a great health rating, its profitability is only average at the moment. MYRG is growing strongly while it is still valued neutral. This is a good combination! These ratings would make MYRG suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. MYRG Profitability Analysis

1.1 Basic Checks

  • MYRG had positive earnings in the past year.
  • In the past year MYRG had a positive cash flow from operations.
  • In the past 5 years MYRG has always been profitable.
  • Each year in the past 5 years MYRG had a positive operating cash flow.
MYRG Yearly Net Income VS EBIT VS OCF VS FCFMYRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.20%, MYRG is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
  • MYRG has a better Return On Equity (17.93%) than 69.64% of its industry peers.
  • MYRG's Return On Invested Capital of 13.27% is fine compared to the rest of the industry. MYRG outperforms 73.21% of its industry peers.
  • MYRG had an Average Return On Invested Capital over the past 3 years of 9.21%. This is significantly below the industry average of 17.18%.
  • The last Return On Invested Capital (13.27%) for MYRG is above the 3 year average (9.21%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.2%
ROE 17.93%
ROIC 13.27%
ROA(3y)5%
ROA(5y)5.71%
ROE(3y)12.31%
ROE(5y)13.64%
ROIC(3y)9.21%
ROIC(5y)10.23%
MYRG Yearly ROA, ROE, ROICMYRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.24%, MYRG is in line with its industry, outperforming 53.57% of the companies in the same industry.
  • In the last couple of years the Profit Margin of MYRG has grown nicely.
  • The Operating Margin of MYRG (4.45%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of MYRG has grown nicely.
  • Looking at the Gross Margin, with a value of 11.59%, MYRG is doing worse than 69.64% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MYRG has remained more or less at the same level.
Industry RankSector Rank
OM 4.45%
PM (TTM) 3.24%
GM 11.59%
OM growth 3Y5.93%
OM growth 5Y3.6%
PM growth 3Y5.31%
PM growth 5Y4.35%
GM growth 3Y0.44%
GM growth 5Y-1.15%
MYRG Yearly Profit, Operating, Gross MarginsMYRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

8

2. MYRG Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MYRG is still creating some value.
  • Compared to 1 year ago, MYRG has less shares outstanding
  • The number of shares outstanding for MYRG has been reduced compared to 5 years ago.
  • MYRG has a better debt/assets ratio than last year.
MYRG Yearly Shares OutstandingMYRG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
MYRG Yearly Total Debt VS Total AssetsMYRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 5.71 indicates that MYRG is not in any danger for bankruptcy at the moment.
  • MYRG has a better Altman-Z score (5.71) than 78.57% of its industry peers.
  • MYRG has a debt to FCF ratio of 0.26. This is a very positive value and a sign of high solvency as it would only need 0.26 years to pay back of all of its debts.
  • MYRG's Debt to FCF ratio of 0.26 is amongst the best of the industry. MYRG outperforms 89.29% of its industry peers.
  • MYRG has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.08, MYRG is doing good in the industry, outperforming 76.79% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.26
Altman-Z 5.71
ROIC/WACC1.31
WACC10.15%
MYRG Yearly LT Debt VS Equity VS FCFMYRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • MYRG has a Current Ratio of 1.33. This is a normal value and indicates that MYRG is financially healthy and should not expect problems in meeting its short term obligations.
  • MYRG's Current ratio of 1.33 is fine compared to the rest of the industry. MYRG outperforms 62.50% of its industry peers.
  • MYRG has a Quick Ratio of 1.33. This is a normal value and indicates that MYRG is financially healthy and should not expect problems in meeting its short term obligations.
  • MYRG has a better Quick ratio (1.33) than 66.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.33
MYRG Yearly Current Assets VS Current LiabilitesMYRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

8

3. MYRG Growth Analysis

3.1 Past

  • MYRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 307.03%, which is quite impressive.
  • Measured over the past years, MYRG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.69% on average per year.
  • MYRG shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.79%.
  • The Revenue has been growing by 10.23% on average over the past years. This is quite good.
EPS 1Y (TTM)307.03%
EPS 3Y15.32%
EPS 5Y16.69%
EPS Q2Q%135.35%
Revenue 1Y (TTM)8.79%
Revenue growth 3Y6.73%
Revenue growth 5Y10.23%
Sales Q2Q%17.32%

3.2 Future

  • Based on estimates for the next years, MYRG will show a very strong growth in Earnings Per Share. The EPS will grow by 20.12% on average per year.
  • Based on estimates for the next years, MYRG will show a quite strong growth in Revenue. The Revenue will grow by 8.40% on average per year.
EPS Next Y23.25%
EPS Next 2Y18.64%
EPS Next 3Y18.6%
EPS Next 5Y20.12%
Revenue Next Year10.54%
Revenue Next 2Y9.03%
Revenue Next 3Y9.15%
Revenue Next 5Y8.4%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MYRG Yearly Revenue VS EstimatesMYRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
MYRG Yearly EPS VS EstimatesMYRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

4

4. MYRG Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 35.50, which means the current valuation is very expensive for MYRG.
  • MYRG's Price/Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 26.46, MYRG is valued a bit more expensive.
  • MYRG is valuated quite expensively with a Price/Forward Earnings ratio of 28.80.
  • MYRG's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 24.65. MYRG is around the same levels.
Industry RankSector Rank
PE 35.5
Fwd PE 28.8
MYRG Price Earnings VS Forward Price EarningsMYRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MYRG is on the same level as its industry peers.
  • 82.14% of the companies in the same industry are more expensive than MYRG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.89
EV/EBITDA 17.74
MYRG Per share dataMYRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

  • MYRG's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of MYRG may justify a higher PE ratio.
  • A more expensive valuation may be justified as MYRG's earnings are expected to grow with 18.60% in the coming years.
PEG (NY)1.53
PEG (5Y)2.13
EPS Next 2Y18.64%
EPS Next 3Y18.6%

0

5. MYRG Dividend Analysis

5.1 Amount

  • No dividends for MYRG!.
Industry RankSector Rank
Dividend Yield 0%

MYRG Fundamentals: All Metrics, Ratios and Statistics

MYR GROUP INC/DELAWARE

NASDAQ:MYRG (3/9/2026, 8:24:10 PM)

After market: 267.31 0 (0%)

267.31

+6.41 (+2.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-25
Earnings (Next)04-28
Inst Owners102.36%
Inst Owner Change-2.59%
Ins Owners1.59%
Ins Owner Change1.06%
Market Cap4.15B
Revenue(TTM)3.66B
Net Income(TTM)118.42M
Analysts81.43
Price Target265.35 (-0.73%)
Short Float %4.32%
Short Ratio2.87
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.54%
Min EPS beat(2)4.94%
Max EPS beat(2)22.14%
EPS beat(4)4
Avg EPS beat(4)13.91%
Min EPS beat(4)4.94%
Max EPS beat(4)22.14%
EPS beat(8)6
Avg EPS beat(8)-0.68%
EPS beat(12)8
Avg EPS beat(12)1.66%
EPS beat(16)10
Avg EPS beat(16)3.41%
Revenue beat(2)2
Avg Revenue beat(2)3.56%
Min Revenue beat(2)0.82%
Max Revenue beat(2)6.29%
Revenue beat(4)4
Avg Revenue beat(4)4.16%
Min Revenue beat(4)0.82%
Max Revenue beat(4)6.29%
Revenue beat(8)4
Avg Revenue beat(8)-0.46%
Revenue beat(12)8
Avg Revenue beat(12)2.66%
Revenue beat(16)12
Avg Revenue beat(16)3.5%
PT rev (1m)0%
PT rev (3m)8.12%
EPS NQ rev (1m)-1.25%
EPS NQ rev (3m)-2.3%
EPS NY rev (1m)2.08%
EPS NY rev (3m)2.71%
Revenue NQ rev (1m)0.14%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)0.82%
Revenue NY rev (3m)0.85%
Valuation
Industry RankSector Rank
PE 35.5
Fwd PE 28.8
P/S 1.14
P/FCF 17.89
P/OCF 12.72
P/B 6.29
P/tB 8.79
EV/EBITDA 17.74
EPS(TTM)7.53
EY2.82%
EPS(NY)9.28
Fwd EY3.47%
FCF(TTM)14.94
FCFY5.59%
OCF(TTM)21.01
OCFY7.86%
SpS235.39
BVpS42.5
TBVpS30.42
PEG (NY)1.53
PEG (5Y)2.13
Graham Number84.85
Profitability
Industry RankSector Rank
ROA 7.2%
ROE 17.93%
ROCE 19.16%
ROIC 13.27%
ROICexc 16.12%
ROICexgc 22.04%
OM 4.45%
PM (TTM) 3.24%
GM 11.59%
FCFM 6.35%
ROA(3y)5%
ROA(5y)5.71%
ROE(3y)12.31%
ROE(5y)13.64%
ROIC(3y)9.21%
ROIC(5y)10.23%
ROICexc(3y)10.27%
ROICexc(5y)11.41%
ROICexgc(3y)13.83%
ROICexgc(5y)15.32%
ROCE(3y)13.3%
ROCE(5y)14.76%
ROICexgc growth 3Y10.53%
ROICexgc growth 5Y9.41%
ROICexc growth 3Y12.09%
ROICexc growth 5Y8.06%
OM growth 3Y5.93%
OM growth 5Y3.6%
PM growth 3Y5.31%
PM growth 5Y4.35%
GM growth 3Y0.44%
GM growth 5Y-1.15%
F-Score7
Asset Turnover2.22
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.26
Debt/EBITDA 0.24
Cap/Depr 141.89%
Cap/Sales 2.58%
Interest Coverage 31.73
Cash Conversion 142.53%
Profit Quality 196.08%
Current Ratio 1.33
Quick Ratio 1.33
Altman-Z 5.71
F-Score7
WACC10.15%
ROIC/WACC1.31
Cap/Depr(3y)133.89%
Cap/Depr(5y)129.49%
Cap/Sales(3y)2.39%
Cap/Sales(5y)2.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)307.03%
EPS 3Y15.32%
EPS 5Y16.69%
EPS Q2Q%135.35%
EPS Next Y23.25%
EPS Next 2Y18.64%
EPS Next 3Y18.6%
EPS Next 5Y20.12%
Revenue 1Y (TTM)8.79%
Revenue growth 3Y6.73%
Revenue growth 5Y10.23%
Sales Q2Q%17.32%
Revenue Next Year10.54%
Revenue Next 2Y9.03%
Revenue Next 3Y9.15%
Revenue Next 5Y8.4%
EBIT growth 1Y244.31%
EBIT growth 3Y13.06%
EBIT growth 5Y14.2%
EBIT Next Year89.13%
EBIT Next 3Y35.32%
EBIT Next 5Y25.62%
FCF growth 1Y1977.44%
FCF growth 3Y36.94%
FCF growth 5Y12.16%
OCF growth 1Y274.87%
OCF growth 3Y24.93%
OCF growth 5Y13.26%

MYR GROUP INC/DELAWARE / MYRG FAQ

What is the fundamental rating for MYRG stock?

ChartMill assigns a fundamental rating of 6 / 10 to MYRG.


What is the valuation status for MYRG stock?

ChartMill assigns a valuation rating of 4 / 10 to MYR GROUP INC/DELAWARE (MYRG). This can be considered as Fairly Valued.


How profitable is MYR GROUP INC/DELAWARE (MYRG) stock?

MYR GROUP INC/DELAWARE (MYRG) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for MYRG stock?

The Earnings per Share (EPS) of MYR GROUP INC/DELAWARE (MYRG) is expected to grow by 23.25% in the next year.